Ancel Keys

Bio: Ancel Keys is an academic researcher from University of Minnesota. The author has contributed to research in topics: Blood serum & Blood chemistry. The author has an hindex of 75, co-authored 310 publications receiving 33437 citations. Previous affiliations of Ancel Keys include Hong Kong Environmental Protection Department & Hastings Entertainment.

Densitometric analysis of body composition: revision of some quantitative assumptions*

Abstract: One can trace to Archimedes the idea that in a system consisting of two additive components which are mixed but the densities of which are known ( d l , d 2 ) , the determination of the density of the system ( D ) allows one to calculate the proportional masses of the two components. Let’s denote these components as W1 and W2.S Then, in a system with total weight W = W1 + Wz, the general equation for calculating component W1 expressed as a fraction (w1) of the total body weight is:

The diet and 15-year death rate in the seven countries study.

Abstract: In 15 cohorts of the Seven Countries Study comprising 11579 men aged 40-59 years and healthy at entry 2288 died in 15 years. Death rates differed among cohorts. Differences in mean age blood pressure serum cholesterol and smoking habits explained 46% of variance in death rate from all causes 80% from coronary heart disease 35% from cancer and 45% from stroke....Death rates were related positively to average percentage of dietary energy from saturated fatty acids negatively to dietary energy percentage from monounsaturated fatty acids and were unrelated to dietary energy percentage from polyunsaturated fatty acids proteins carbohydrates and alcohol. Inclusion of the ratio of monounsaturated to saturated fatty acids "with age blood pressure serum cholesterol and smoking habits as independent variables accounted for 85% of variance in rates of deaths from all causes 96% coronary heart disease 55% cancer and 66% stroke....All-cause and coronary heart disease death rates were low in cohorts with olive oil as the main fat. Causal relationships are not claimed but consideration of characteristics of populations as well as of individuals within populations is urged in evaluating risks." The study covered subpopulations in the United States Finland the Netherlands Italy Yugoslavia Greece and Japan. (EXCERPT)

Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research.

Abstract: "Physical activity," "exercise," and "physical fitness" are terms that describe different concepts. However, they are often confused with one another, and the terms are sometimes used interchangeably. This paper proposes definitions to distinguish them. Physical activity is defined as any bodily movement produced by skeletal muscles that results in energy expenditure. The energy expenditure can be measured in kilocalories. Physical activity in daily life can be categorized into occupational, sports, conditioning, household, or other activities. Exercise is a subset of physical activity that is planned, structured, and repetitive and has as a final or an intermediate objective the improvement or maintenance of physical fitness. Physical fitness is a set of attributes that are either health- or skill-related. The degree to which people have these attributes can be measured with specific tests. These definitions are offered as an interpretational framework for comparing studies that relate physical activity, exercise, and physical fitness to health.

European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012)

Abstract: ABI : ankle–brachial index ACCORD : Action to Control Cardiovascular Risk in Diabetes ADVANCE : Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation AGREE : Appraisal of Guidelines Research and Evaluation AHA : American Heart Association apoA1 : apolipoprotein A1 apoB : apolipoprotein B CABG : coronary artery bypass graft surgery CARDS : Collaborative AtoRvastatin Diabetes Study CCNAP : Council on Cardiovascular Nursing and Allied Professions CHARISMA : Clopidogrel for High Athero-thrombotic Risk and Ischemic Stabilisation, Management, and Avoidance CHD : coronary heart disease CKD : chronic kidney disease COMMIT : Clopidogrel and Metoprolol in Myocardial Infarction Trial CRP : C-reactive protein CURE : Clopidogrel in Unstable Angina to Prevent Recurrent Events CVD : cardiovascular disease DALYs : disability-adjusted life years DBP : diastolic blood pressure DCCT : Diabetes Control and Complications Trial ED : erectile dysfunction eGFR : estimated glomerular filtration rate EHN : European Heart Network EPIC : European Prospective Investigation into Cancer and Nutrition EUROASPIRE : European Action on Secondary and Primary Prevention through Intervention to Reduce Events GFR : glomerular filtration rate GOSPEL : Global Secondary Prevention Strategies to Limit Event Recurrence After MI GRADE : Grading of Recommendations Assessment, Development and Evaluation HbA1c : glycated haemoglobin HDL : high-density lipoprotein HF-ACTION : Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing HOT : Hypertension Optimal Treatment Study HPS : Heart Protection Study HR : hazard ratio hsCRP : high-sensitivity C-reactive protein HYVET : Hypertension in the Very Elderly Trial ICD : International Classification of Diseases IMT : intima-media thickness INVEST : International Verapamil SR/Trandolapril JTF : Joint Task Force LDL : low-density lipoprotein Lp(a) : lipoprotein(a) LpPLA2 : lipoprotein-associated phospholipase 2 LVH : left ventricular hypertrophy MATCH : Management of Atherothrombosis with Clopidogrel in High-risk Patients with Recent Transient Ischaemic Attack or Ischaemic Stroke MDRD : Modification of Diet in Renal Disease MET : metabolic equivalent MONICA : Multinational MONItoring of trends and determinants in CArdiovascular disease NICE : National Institute of Health and Clinical Excellence NRT : nicotine replacement therapy NSTEMI : non-ST elevation myocardial infarction ONTARGET : Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial OSA : obstructive sleep apnoea PAD : peripheral artery disease PCI : percutaneous coronary intervention PROactive : Prospective Pioglitazone Clinical Trial in Macrovascular Events PWV : pulse wave velocity QOF : Quality and Outcomes Framework RCT : randomized clinical trial RR : relative risk SBP : systolic blood pressure SCORE : Systematic Coronary Risk Evaluation Project SEARCH : Study of the Effectiveness of Additional Reductions in Cholesterol and SHEP : Systolic Hypertension in the Elderly Program STEMI : ST-elevation myocardial infarction SU.FOL.OM3 : SUpplementation with FOlate, vitamin B6 and B12 and/or OMega-3 fatty acids Syst-Eur : Systolic Hypertension in Europe TNT : Treating to New Targets UKPDS : United Kingdom Prospective Diabetes Study VADT : Veterans Affairs Diabetes Trial VALUE : Valsartan Antihypertensive Long-term Use VITATOPS : VITAmins TO Prevent Stroke VLDL : very low-density lipoprotein WHO : World Health Organization ### 1.1 Introduction Atherosclerotic cardiovascular disease (CVD) is a chronic disorder developing insidiously throughout life and usually progressing to an advanced stage by the time symptoms occur. It remains the major cause of premature death in Europe, even though CVD mortality has …

Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years

Abstract: The fat content of the human body has physiological and medical importance. It may influence morbidity and mortality, it may aIter the effectiveness of drugs and anaesthetics, and it may affect the ability to withstand exposure to cold and starvation. Thus the measurement of the total body fat provides useful information. In many people, but by no means everyone, a moderately satisfactory estimate of the body fat content can be obtained from the height and weight. However, for more precise evaluation several methods are available which give a reasonably accurate measure of body fat both in normal subjects and in individuals with unusual body builds. Most of these methods are based on the assumption that the body can be considered to consist of two compartments of relatively constant composition but which are distinctly different; these compartments are: (I) the body fat, which includes the entire content of chemical fat or lipids in the body, and (2) the fat-free mass (FFM), which includes all the rest of the body apart from fat. The body fat compartment is anhydrous, contains no potassium and has a fairly constant density of about 0.90 x 103 kg/m3. The fat-free compartment on the other hand probably has a fairly constant density of about 1.10 x 103 kg/m3, a potassium content of about 68 mequiv./kg in males (about 10% less in females) and a water content of about 720 g/kg. Thus measurement of body density or of total body K or of total body water allows a calculation of the relative proportion of these two compartments in the body and therefore also of the total fat content. The accuracy of these measures, however, is limited by the variability of the composition and density of the fat-free compartment in different individuals. In particular, individuals with a relatively high or

A receptor-mediated pathway for cholesterol homeostasis.

Abstract: In 1901 a physician, Archibald Garrod, observed a patient with black urine. He used this simple observation to demonstrate that a single mutant gene can produce a discrete block in a biochemical pathway, which he called an “inborn error of metabolism”. Garrod’s brilliant insight anticipated by 40 years the one gene-one enzyme concept of Beadle and Tatum. In similar fashion the chemist Linus Pauling and the biochemist Vernon Ingram, through study of patients with sickle cell anemia, showed that mutant genes alter the amino acid sequences of proteins. Clearly, many fundamental advances in biology were spawned by perceptive studies of human genetic diseases (1). We began our work in 1972 in an attempt to understand a human genetic disease, familial hypercholesterolemia or FH. In these patients the concentration of cholesterol in blood is elevated many fold above normal and heart attacks occur early in life. We postulated that this dominantly inherited disease results from a failure of end-product repression of cholesterol synthesis. The possibility fascinated us because genetic defects in feedback regulation had not been observed previously in humans or animals, and we hoped that study of this disease might throw light on fundamental regulatory mechanisms. Our approach was to apply the techniques of cell culture to unravel the postulated regulatory defect in FH. These studies led to the discovery of a cell surface receptor for a plasma cholesterol transport protein called low density lipoprotein (LDL) and to the elucidation of the mechanism by which this receptor mediates feedback control of cholesterol synthesis (2,3). FH was shown to be caused by inherited defects in the gene encoding the LDL receptor, which disrupt the normal control of cholesterol metabolism. Study of the LDL receptor in turn led to the understanding of receptor-mediated endocytosis, a genera! process by which cells communicate with each other through internalization of regulatory and nutritional molecules (4). Receptor-mediated endocytosis differs from previously described biochemical pathways because it depends upon the continuous and highly controlled movement of membraneembedded proteins from one cell organelle to another in a process termed